Authors:
Warshofsky, MK
Dominguez, M
Eisenberg, MS
Wasserman, HS
Sciacca, R
Wang, WZ
Simon, AD
Morse, JH
Schwartz, A
Angles-Cano, E
Rabbani, LE
Citation: Mk. Warshofsky et al., Elevated plasma tissue plasminogen activator and anti-THP-1 antibodies areindependently associated with decreased graft survival in cardiac transplant recipients, AM J CARD, 88(1), 2001, pp. 30-34
Authors:
Deng, ZM
Haghighi, F
Helleby, L
Vanterpool, K
Horn, EM
Barst, RJ
Hodge, SE
Morse, JH
Knowles, JA
Citation: Zm. Deng et al., Fine mapping of PPH1, a gene for familial primary pulmonary hypertension, to a 3-cM region on chromosome 2q33, AM J R CRIT, 161(3), 2000, pp. 1055-1059
Authors:
Morse, JH
Antohi, S
Kasturi, K
Saito, S
Fotino, M
Humbert, M
Simonneau, G
Basst, RJ
Bona, CA
Citation: Jh. Morse et al., Fine specificity of anti-fibrillin-1 autoantibodies in primary pulmonary hypertension syndrome, SC J IMMUN, 51(6), 2000, pp. 607-611
Authors:
Deng, ZM
Morse, JH
Slager, SL
Cuervo, N
Moore, KJ
Venetos, G
Kalachikov, S
Cayanis, E
Fischer, SG
Barst, RJ
Hodge, SE
Knowles, JA
Citation: Zm. Deng et al., Familial primary pulmonary hypertension (gene PPH1) is caused by mutationsin the bone morphogenetic protein receptor-II gene, AM J HU GEN, 67(3), 2000, pp. 737-744
Citation: Jh. Morse et al., Hormone replacement therapy - A possible risk factor in carriers of familial primary pulmonary hypertension, CHEST, 116(3), 1999, pp. 847-847